Summary
Regeneron Pharmaceuticals, Inc. (REGN) filed a Form 8-K on December 22, 2014, to report a significant organizational change. The company announced that Murray A. Goldberg, Senior Vice President of Administration and Assistant Secretary, will transition from his full-time officer role effective March 31, 2015. He will then move to a part-time employment arrangement with the company starting April 1, 2015. This transition marks the end of Mr. Goldberg's tenure as a full-time officer, though his continued involvement in a part-time capacity suggests his expertise remains valued. Investors should note Mr. Goldberg's prior long-standing role as Chief Financial Officer from March 1995 to October 2013, highlighting his deep institutional knowledge. His compensation in the part-time role will be based on hours worked, indicating a more flexible engagement model.
Key Highlights
- 1Murray A. Goldberg, Senior Vice President, Administration and Assistant Secretary, will resign as an officer effective March 31, 2015.
- 2Mr. Goldberg will transition to a part-time employment role with Regeneron starting April 1, 2015.
- 3This change reflects a shift in Mr. Goldberg's responsibilities, not a complete departure from the company.
- 4Mr. Goldberg previously served as Chief Financial Officer from March 1995 to October 2013.
- 5His part-time compensation will be determined by the number of hours he works.
- 6The filing is dated December 22, 2014, with the earliest event reported on December 19, 2014.